March 20th, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
March 20th, 2018
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
March 15th, 2018
HoliStick Medical licenses surgical catheter technology from Harvard and collaborators for further development
March 2nd, 2018
Update on patent enforcement
March 1st, 2018
Innovations in vapor deposition, nanosensors, synthesis of moenomycin analogs, single-cell barcoding, graphene inks, and more
February 28th, 2018
Quebec-based Boréas Technologies launches out of Harvard to help electronics companies cross the next sensory frontier